2016IP International Journal of Orthopaedic RheumatologyRequires access

Zolindronic Acid in Osteoporosis- A Dexa Study

M. Vijay Balaji, Sathish Devadoss, A. Victor Devadoss, Sreekanth Gunti

Open publisher page 0 citations

Abstract

Background: Osteoporosis a systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. We present our study analyzing the effect of Intravenous zolendronic therapy in osteoporotic individuals using the Dual Energy X-ray Absorptiometry Scan. Materials and method: All patients above 50 yrs of age with osteoporosis measured by DEXA Scan of Lumbar Spine BMD (T-score

About this research paper

What this paper is about

Background: Osteoporosis a systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. We present our study analyzing the effect of Intravenous zolendronic therapy in osteoporotic individuals using the Dual Energy X-ray Absorptiometry Scan. Materials and method: All patients above 50 yrs of age with osteoporosis measured by DEXA Scan of Lumbar Spine BMD (T-score

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background: Osteoporosis a systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. We present our study analyzing the effect of Intravenous zolendronic therapy in osteoporotic individuals using the Dual Energy X-ray Absorptiometry Scan. Materials and method: All patients above 50 yrs of age with osteoporosis measured by DEXA Scan of Lumbar Spine BMD (T-score

Key concepts: Osteoporosis, Medicine, Dual energy, Bone mass, Lumbar spine, Fragility fracture, Dual-energy X-ray absorptiometry, Bone disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Zolindronic Acid in Osteoporosis- A Dexa Study — Research Paper | ScholarLens